Abstract: An apparatus for measuring flow of cryogen exhaust gas from a freezer includes a flow probe with a resistive heater and a flow probe control. The flow probe control is coupled to the flow probe and the flow probe control includes a control circuit configured to operate the resistive heater at a first temperature for a first period of time, operate the resistive heater at a second temperature for a second period of time, and determine a heat transfer coefficient at the flow probe. The first temperature and the second temperature are different and at least one of the first and second temperatures is greater than a predetermined threshold temperature. A related method is also provided.

Abstract: An apparatus for measuring flow of cryogen exhaust gas from a freezer includes a flow probe with a resistive heater and a flow probe control. The flow probe control is coupled to the flow probe and the flow probe control includes a control circuit configured to operate the resistive heater at a first temperature for a first period of time, operate the resistive heater at a second temperature for a second period of time, and determine a heat transfer coefficient at the flow probe. The first temperature and the second temperature are different and at least one of the first and second temperatures is greater than a predetermined threshold temperature. A related method is also provided.

Abstract: A system for externally cooling a radiation shielded cask containing heat-emitting high level radioactive waste such as spent nuclear fuel. The system includes the cask defining an internal cavity configured to hold an unshielded canister containing the spent nuclear fuel. An annular cooling water header extends circumferentially around the entire circumference of the cylindrical sidewall of the cask. The header comprises plural dispensing outlets which direct cooling water onto the cask, thereby wetting the entire sidewall of the cask. The cooling water provides an external heat sink for absorbing the heat emitted through the external wall surface of the cask generated by the spent nuclear fuel. In various embodiments, the cooling water header may have a continuous annular structure, or be formed by two or more header segments. The header may be supported directly from the cask by detachably mounted brackets.

Abstract: A system for externally cooling a radiation shielded cask containing heat-emitting high level radioactive waste such as spent nuclear fuel. The system includes the cask defining an internal cavity configured to hold an unshielded canister containing the spent nuclear fuel. An annular cooling water header extends circumferentially around the entire circumference of the cylindrical sidewall of the cask. The header comprises plural dispensing outlets which direct cooling water onto the cask, thereby wetting the entire sidewall of the cask. The cooling water provides an external heat sink for absorbing the heat emitted through the external wall surface of the cask generated by the spent nuclear fuel. In various embodiments, the cooling water header may have a continuous annular structure, or be formed by two or more header segments. The header may be supported directly from the cask by detachably mounted brackets.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated syringe or other aspirator and dispenser accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate according to the RPR or other agglutination test. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent, to evaluate whether the specimen is reactive or non-reactive. Test results and photographic evidence of the test results are preferably archived within a database.

Abstract: The automated reader operates within an enclosure also containing a sample rack and reagent rack, as well as a microtiter plate with multiple wells therein. The machine automatically loads sample and reagent into a well of the microtiter plate according to a testing protocol. The specimen can then be moved along with the microtiter plate into a slot of the reader and aligned with either a light source and detector for an optical density read or aligned with a photon counter for a chemiluminescence read. The reader includes a shroud assembly which can be raised and lowered by a lift assembly to occlude a read point from photons other than those emanating from the sample.

Abstract: The present invention relates to a method of photodynamic therapy and to a method of inducing a photocytoxic effect which comprises applying to an area to be treated an effective amount of a compound of formula in which R1, R2, R3 and R4 each independently is an optionally-substituted linear, branched or cyclic hydrocarbon group, or R1 and R2 together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring or R3 and R4 together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which —NR1R2 and —NR3R4 are the same and are selected from —N(CH3)2 or —N(CH2CH3)2; and exposing the area to light to activate the compound.

Abstract: The present invention relates to a composition which includes a moiety of formula wherein R1, R2, R3 and R4 each represent n-pentyl, and to a method of sterilizing a su fluid using same.

Abstract: Described are compositions and methods effective to improve the security obtainable for red phosphorescent inks printed, such as by ink jet printing. Specially designed polymeric chelating agents are water soluble and have a high chelating efficiency for lanthanide cations and are themselves strongly adsorbed on polymeric substrates, especially paper. The polymeric chelating agents comprise a polymer chain of either general formulae (1) or (2) containing pyridine-N-oxide, quinoline-N-oxide or isoquinoline-N oxide pendent ligand groups A, where m and n are independent integers in the range of from 1 to 10, and the number average molecular weight of the polymers lies in the range from 1×103 to 5×105: In one aspect a polymeric chelate as described is produced in situ in an aqueous ink formulation and is subsequently printed onto a substrate and dried.

Abstract: The present invention relates to a method of photodynamic therapy and to a method of inducing a photocytoxic effect which comprises applying to an area to be treated an effective amount of a compound of formula in which R1, R2, R3 and R4 each independently is an optionally -substituted linear, branched or cyclic hydrocarbon group, or R1 and R2 together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7- membered ring or R3 and R4 together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7- membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which —NR1R2 and —NR3R4 are the same and are selected from —N(CH3)2 or —N(CH2CH3)2; and exposing the area to light to activate the compound.

Abstract: A phenothiazinium compound of Formula (I) wherein: A and B each independently is in which R? and R? each independently is a linear, branched or cyclic hydrocarbon group, or R? and R? together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which A and B are both either —N(CH3)2 or —N(CH2CH3)2 for use in a treatment that requires removal, deactivation or killing of unwanted tissues or cells.

Abstract: The present invention relates to a pharmaceutical composition which contains a compound of formula in which R1, R2, R3 and R4 are each n-butyl, where XP? is a counteranion and P is 1, 2 or 3, together with a pharmaceutically acceptable carrier, excipient or adjuvant.

Abstract: Described are compositions and methods effective to improve the security obtainable for red phosphorescent inks printed, such as by ink jet printing. Specially designed polymeric chelating agents are water soluble and have a high chelating efficiency for lanthanide cations and are themselves strongly adsorbed on polymeric substrates, especially paper. The polymeric chelating agents comprise a polymer chain of either general formulae (1) or (2) containing pyridine-N-oxide, quinoline-N-oxide or isoquinoline-N oxide pendent ligand groups A, where m and n are independent integers in the range of from 1 to 10, and the number average molecular weight of the polymers lies in the range from 1×103 to 5×105: In one aspect a polymeric chelate as described is produced in situ in an aqueous ink formulation and is subsequently printed onto a substrate and dried.

Abstract: In an electrochemical sensor, the potential difference applied to the electrochemical cell is raised to a measuring value at a rate determined to reduce the transient current. The maximum rate of change of the voltage is set to prevent saturation of an IE converter. The electrochemical cell may contain micro-electrodes as working and reference electrodes. The method may be applied to a battery powered, handheld device.

Abstract: The present invention relates to a phenothiazinium compound of Formula (I): wherein: A and B each independently is in which R? and R? each independently is a linear, branched or cyclic hydrocarbon group, or R? and R? together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which A and B are both either —N(CH3)2 or —N(CH2CH3)2 for use in a treatment that requires removal, deactivation or killing of unwanted tissues or cells. The invention also relates to compositions comprising the compounds of Formula I, to selected compounds of Formula I, use of the compounds of Formula I as medicaments and as a PDT agent or a photodiagnostic agent, a conjugate or composite formed between a compound of Formula I and a polymer; and to a method for sterilising fluids in which the fluid is passed over the conjugate or composite whilst it is illuminated.

Abstract: In an electrochemical sensor, a peak is detected by grouping data points in windows and detecting two or three windows between which the slope of the data changes sign. The peak can be more precisely detected by detecting the highest data point in the two or three windows.

Abstract: A phenothiazinium compound of Formula (I) wherein: A and B each independently is in which R? and R? each independently is a linear, branched or cyclic hydrocarbon group, or R? and R? together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which A and B are both either —N(CH3)2 or —N(CH2CH3)2 for use in a treatment that requires removal, deactivation or killing of unwanted tissues or cells.

Abstract: The present invention relates to a phenothiazinium compound of Formula (I): wherein: A and B each independently is in which R? and R? each independently is a linear, branched or cyclic hydrocarbon group, or R? and R? together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where XP? is a counteranion and P is 1, 2 or 3; except for the compounds in which A and B are both either —N(CH3)2 or —N(CH2CH3)2 for use in a treatment that requires removal, deactivation or killing of unwanted tissues or cells. The invention also relates to compositions comprising the compounds of Formula I, to selected compounds of Formula I, use of the compounds of Formula I as medicaments and as a PDT agent or a photodiagnostic agent, a conjugate or composite formed between a compound of Formula I and a polymer; and to a method for sterilising fluids in which the fluid is passed over the conjugate or composite whilst it is illuminated.